Delivery Order SPE2DB24D3015-SPE2DB26FFWXU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,927.84 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a $16,728.21 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 5, 2025, with performance fulfillment from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,793.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 10, 2025, with completion scheduled for September 11, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $11,243.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and...
- The Defense Logistics Agency awarded a delivery order valued at $16,941.31 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a direct fulfillment order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This contract is a non-set-aside, competitively awarded delivery order with a firm fixed price ceiling value of $12,911.85 and an ultimate completion date of November 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $44,263.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant medication commonly used in...
- The Defense Logistics Agency awarded a $16,631.46 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWXUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,498.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on November 12, 2025, with completion expected by November 13, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement to support military healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs and maintains extensive contracts with the DLA for medical commodities delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies globally to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. Eliquis, an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, represents one of the specialized pharmaceutical products available through this expansive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 11/12/25 |